Skip to content
Erudio Health
menu
Clinical trial · no report yet · Phase not applicable

RAVES

Radiotherapy - Adjuvant Versus Early Salvage

  • NCT00860652 ↗
  • Active not recruiting
  • Trans Tasman Radiation Oncology Group
  • 31 commentary sources found
  • Standard

We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.

Commentary we found

Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built.

ChannelFound
X threads22
Podcasts5
YouTube4

The trial

ClinicalTrials.gov
Official title
Radiotherapy - Adjuvant Versus Early Salvage. A Phase III Multi-centre Randomised Trial Comparing Adjuvant Radiotherapy (RT) With Early Salvage RT in Patients With Positive Margins or Extraprostatic Disease Following Radical Prostatectomy.
Phase
Phase not applicable
Status
Active not recruiting
Conditions
Prostate Cancer
Interventions
Adjuvant Radiotherapy; Early Salvage Radiotherapy
Arms
  • Adjuvant Radiotherapy (RT) · Experimental
  • Active Surveillance with Early SalvageRT · Experimental
Enrollment
333
Primary outcomes
  • Biochemical failure: PSA ≥ 0.4 ng/ml and rising following RT
Sponsor
Trans Tasman Radiation Oncology Group with Urological Society of Australia and New Zealand (USANZ), Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Start
Mar 3, 2009
Primary completion
Dec 2022 (estimated)
Results posted
No
Registry record
NCT00860652 · updated Nov 18, 2022

Publications

linked from the registry
  • Kneebone A, Fraser-Browne C, Duchesne GM, Fisher R, Frydenberg M, Herschtal A, Williams SG, Brown C, Delprado W, Haworth A, Joseph DJ, Martin JM, Matthews JHL, Millar JL, Sidhom M, Spry N, Tang CI, Turner S, Wiltshire KL, Woo HH, Davis ID, Lim TS, Pearse M. Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial. Lancet Oncol. 2020 Oct;21(10):1331-1340. doi: 10.1016/S1470-2045(20)30456-3. PubMed 33002437